全文获取类型
收费全文 | 23329篇 |
免费 | 1484篇 |
国内免费 | 76篇 |
专业分类
耳鼻咽喉 | 361篇 |
儿科学 | 1190篇 |
妇产科学 | 540篇 |
基础医学 | 2087篇 |
口腔科学 | 409篇 |
临床医学 | 1805篇 |
内科学 | 5499篇 |
皮肤病学 | 373篇 |
神经病学 | 1240篇 |
特种医学 | 765篇 |
外科学 | 4211篇 |
综合类 | 540篇 |
一般理论 | 5篇 |
预防医学 | 1294篇 |
眼科学 | 960篇 |
药学 | 1915篇 |
中国医学 | 134篇 |
肿瘤学 | 1561篇 |
出版年
2023年 | 167篇 |
2022年 | 137篇 |
2021年 | 896篇 |
2020年 | 475篇 |
2019年 | 700篇 |
2018年 | 809篇 |
2017年 | 549篇 |
2016年 | 584篇 |
2015年 | 595篇 |
2014年 | 909篇 |
2013年 | 1150篇 |
2012年 | 1739篇 |
2011年 | 1600篇 |
2010年 | 965篇 |
2009年 | 773篇 |
2008年 | 1208篇 |
2007年 | 1198篇 |
2006年 | 1108篇 |
2005年 | 1059篇 |
2004年 | 947篇 |
2003年 | 815篇 |
2002年 | 717篇 |
2001年 | 541篇 |
2000年 | 575篇 |
1999年 | 456篇 |
1998年 | 198篇 |
1997年 | 158篇 |
1996年 | 135篇 |
1995年 | 131篇 |
1994年 | 119篇 |
1993年 | 91篇 |
1992年 | 303篇 |
1991年 | 276篇 |
1990年 | 234篇 |
1989年 | 232篇 |
1988年 | 186篇 |
1987年 | 189篇 |
1986年 | 172篇 |
1985年 | 183篇 |
1984年 | 157篇 |
1983年 | 149篇 |
1982年 | 70篇 |
1981年 | 78篇 |
1979年 | 123篇 |
1978年 | 94篇 |
1977年 | 68篇 |
1974年 | 81篇 |
1973年 | 115篇 |
1972年 | 103篇 |
1971年 | 72篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Elan L. Guterman Hooman Kamel Carmil Azran Maulik P. Shah J. Claude Hemphill III Wade S. Smith Babak B. Navi 《Neurocritical care》2014,21(1):85-90
Introduction
The interval from presentation with systemic inflammatory response syndrome (SIRS) to the start of antibiotic administration affects mortality in patients with sepsis. However, patients with subarachnoid hemorrhage (SAH) often develop SIRS directly from their brain injury, making it a less useful indicator of infection. We therefore hypothesized that SIRS would not be a suitable trigger for antibiotics in this population.Methods
We examined the time from the development of SIRS until antibiotic initiation and its relationship to long-term neurological outcomes in patients with nontraumatic SAH. Patients’ baseline characteristics, time of antibiotic administration, and hospital course were collected from retrospective chart review. The primary outcome, 6-month functional status, was prospectively determined using blinded, structured interviews incorporating the modified Rankin Scale (mRS).Results
Sixty-six of 70 patients with SAH during the study period had 6-month follow-up and were included in this analysis. SIRS developed in 57 patients (86 %, 95 % CI 78–95 %). In ordinal logistic regression models controlling for age and illness severity, the time from SIRS onset until antibiotic initiation was not associated with 6-month mRS scores (OR per hour, 0.994; 95 % CI 0.987–1.001).Conclusions
In this cohort of patients with SAH, time from SIRS onset until antibiotic administration was not related to functional outcomes. Our results indicate that SIRS is nonspecific in patients with SAH, and support the safety of withholding antibiotics in those who lack additional evidence of infection or hemodynamic deterioration. 相似文献993.
994.
Allen S. Ho MD Dennis H. Kraus MD Ian Ganly MD PhD Nancy Y. Lee MD Jatin P. Shah MD Luc G. T. Morris MD MSc 《Head & neck》2014,36(1):144-151
Despite substantial improvements in head and neck squamous cell carcinoma (HNSCC) treatment, the major obstacle to long‐term survival remains disease recurrence. Salvage options are often limited due to prior therapy and the escalated morbidity of retreatment. The costs of treatment must be measured against the anticipated quality and quantity of life recovered, even with resectable disease. This review surveys the recurrent HNSCC literature to better guide decision making. Across multiple studies, negative prognostic factors include impaired performance status, advanced recurrent stage, brief disease‐free interval, previous chemotherapy, and nonlaryngeal sites of recurrence. When possible, surgical salvage remains the principal option for durable disease control, quality of life preservation, and cure. Nonsurgical therapies have also demonstrated measurable improvements in locoregional control. Interpretation of salvage literature must be tempered by recognition of significant selection bias. The decision for salvage therapy must be individualized, with management that involves well‐informed patients resulting in the best outcomes. © 2013 Wiley Periodicals, Inc. Head Neck 36 : 144–151, 2014 相似文献
995.
996.
Jennifer A. Cuthbert Sami Arslanlar Jay Yepuri Marc Montrose Chul W. Ahn Jessica P. Shah 《Digestive diseases and sciences》2014,59(7):1594-1602
Background
No study has evaluated current scoring systems for their accuracy in predicting short and long-term outcome of alcoholic hepatitis in a US population.Methods
We reviewed electronic records for patients with alcoholic liver disease (ALD) admitted to Parkland Memorial Hospital between January 2002 and August 2005. Data and outcomes for 148 of 1,761 admissions meeting pre-defined criteria were collected. The discriminant function (DF) was revised (INRdf) to account for changes in prothrombin time reagents that could potentially affect identification of risk using the previous DF threshold of >32. Admission and theoretical peak scores were calculated by use of the Model for End-stage Liver Disease (MELD). Analysis models compared five different scoring systems.Results
INRdf was closely correlated with the old DF (r 2 = 0.95). Multivariate analysis of the data showed that survival for 28 days was significantly associated with a scoring system using a combination of age, bilirubin, coagulation status, and creatinine (p < 0.001), and an elevated ammonia result within two days of admission (p = 0.012). When peak values for MELD were included, they were the most significant predictor of short-term mortality (p < 0.001), followed by INRdf (p = 0.006).Conclusion
On admission, two scoring systems that identify a subset of patients with severe alcoholic liver disease are able to predict >50 % mortality at four weeks and >80 % mortality at six months without specific treatment. 相似文献997.
998.
999.
1000.
Sunita Sharma Harsh V. Barot Andrew D. Schwartzman Sarju Ganatra Sachin P. Shah David M. Venesy Richard D. Patten 《Clinical cardiology》2020,43(12):1494-1500
BackgroundLeft bundle branch block (LBBB) and left ventricular (LV) dyssynchrony likely contribute to progressive systolic dysfunction. The evaluation of newly recognized LBBB includes screening for structural heart abnormalities and coronary artery disease (CAD). In patients whose LV ejection fraction (EF) is preserved during initial testing, the incidence of subsequent cardiomyopathy is not firmly established.HypothesisThe risk of developing LV systolic dysfunction among LBBB patients with preserved LVEF is high enough to warrant serial imaging.MethodsWe screened records of 1000 consecutive patients with LBBB from our ECG database and identified subjects with an initially preserved LVEF (≥45%) without clinically relevant CAD or other cause for cardiomyopathy. Baseline imaging, clinical data, and follow‐up imaging were recorded to determine the risk of subsequent LV systolic dysfunction (LVEF ≤40%).Results(Data are mean + SD) 784 subjects were excluded, the majority for CAD or depressed LVEF upon initial imaging. Of the remaining 216, 37 (17%) developed a decline in LVEF(≤40%) over a mean follow‐up of 55 ± 31 months; 94% of these patients had a baseline LVEF≤60% and LV end systolic diameter (ESD) ≥ 2.9 cm indicating that these measures may be useful to define which patients warrant longitudinal follow‐up. The negative predictive value of a LVEF>60% and LVESD <2.9 cm was 98%.ConclusionsSeventeen percent of patients with LBBB and initial preserved LVEF develop dyssynchrony cardiomyopathy. We believe the risk of developing dyssynchrony cardiomyopathy is high enough to warrant serial assessment of LV systolic function in this high‐risk population. 相似文献